Cargando…
Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677349/ https://www.ncbi.nlm.nih.gov/pubmed/33208490 http://dx.doi.org/10.1136/esmoopen-2020-001107 |
| _version_ | 1783611952823533568 |
|---|---|
| author | Smyth, Elizabeth C Cervantes, Andrés |
| author_facet | Smyth, Elizabeth C Cervantes, Andrés |
| author_sort | Smyth, Elizabeth C |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7677349 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76773492020-11-30 Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answer Smyth, Elizabeth C Cervantes, Andrés ESMO Open Editorial BMJ Publishing Group 2020-11-18 /pmc/articles/PMC7677349/ /pubmed/33208490 http://dx.doi.org/10.1136/esmoopen-2020-001107 Text en © Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Editorial Smyth, Elizabeth C Cervantes, Andrés Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answer |
| title | Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answer |
| title_full | Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answer |
| title_fullStr | Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answer |
| title_full_unstemmed | Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answer |
| title_short | Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answer |
| title_sort | addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677349/ https://www.ncbi.nlm.nih.gov/pubmed/33208490 http://dx.doi.org/10.1136/esmoopen-2020-001107 |
| work_keys_str_mv | AT smythelizabethc additionofnivolumabtochemotherapyinpatientswithadvancedgastriccancerarelevantstepaheadbutstillmanyquestionstoanswer AT cervantesandres additionofnivolumabtochemotherapyinpatientswithadvancedgastriccancerarelevantstepaheadbutstillmanyquestionstoanswer |